51. Enhanced External Counterpulsation Reduces Blood Pressure in Refractory Angina Pectoris Patients; A Systematic Review and Meta-Analysis

Abstract

Background: In patients with acute coronary syndrome (ACS), the role of admission blood pressure (BP) on outcomes remains inconclusive.Objective: This study aimed to investigate the association between admission BP and various outcomes in patients hospitalized for ACS. Method:In this cross-sectional study, 279 patients who admitted with ACS to Kediri District Hospital and Bogor General Hospital between January and June 2020 were included. Data were analyzed using SPSS software v25.Result: There was association between hypertension status on admission and diagnosis; there were more hypertensive patients with non-ST segment elevation (NSTE) ACS compared to ST segment elevation (STE) ACS diagnosis (p=0.002); and signifi cant difference on admission systolic BP between STE-ACS and NSTE-ACS patients (p<0.00001). Patients who died during hospitalization had signifi cantly lower admission systolic BP compared to survived patients (p=0.001). Patients with reduced ejection fraction (EF) on follow-up echocardiography had signifi cantly lower admission systolic BP compared to patients with normal EF (p=0.014). Patients with diastolic dysfunction on follow-up echocardiography had signifi cantly higher admission systolic BP compared to patients without diastolic dysfunction (p=0.009). No signifi cant difference on length of stay between hypertensive and non-hypertensive patients (p=0.416). Conclusion:Lower admission systolic BP was associated with increased inhospital mortality and reduced EF, while higher systolic BP was associated with diastolic dysfunction.

Enhanced external counterpulsation, focusing on its effect on kidney function, and utilization in patients with kidney diseases: a systematic review

“…EECP has long been shown in patients with coronary artery disease to increase cardiac output, coronary blood flow, and myocardial perfusion via the diastolic augmentation and systolic unloading mechanisms [ 27 , 28 , 29 ]. These beneficial effects have been translated into numerous clinical trials with long-term cardiovascular endpoints and involving patients with various cardiac conditions [ 30 ].…”